secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2026-06-18T20:55:31+00:00
Accession:  0001356576-26-000028
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus shareholders approve all proposals, including equity plan share increase
--------------------------------------------------------------------------------

- Elected Class I directors Frederick M. Hudson (45.1M for) and Charles W. Newhall, III (41.7M for).
- Say-on-pay approved with 45.6M votes for, 1.7M against, 7.7K abstain.
- Ratified KPMG as auditor for FY2026 (49.9M for, 417K against).
- Amendment to 2021 Equity Incentive Plan to increase shares available passed (41.9M for, 5.3M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/0001356576-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/supn-20260618.htm
  HTML page:      https://secwatch.observer/filing/0001356576-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer